Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury

Cardiac dysfunction resulting from sepsis may cause significant morbidity and mortality, and ferroptosis plays a role in this pathology. Dexmedetomidine (Dex), a α2-adrenergic receptor (α2-AR) agonist exerts cardioprotective effects against septic heart dysfunction, but the exact mechanism is unknown. In the present study, sepsis was induced by cecal ligation and puncture (CLP) in male C57BL/6 mice. Dex and yohimbine hydrochloride (YOH), an α2-AR inhibitor, were administered before inducing CLP. Then, 24 h after CLP, serum and heart tissue were collected to detect changes of troponin-I (TN-I), interleukin 6 (IL-6), superoxide dismutase (SOD), malonaldehyde (MDA) and glutathione (GSH) levels, and iron release. Ferroptosis-targeting proteins, apoptosis and inflammatory factors were assessed by western blotting or ELISA. It was found that, 24 h after CLP, TN-I, a biomarker of myocardial injury, was significantly increased compared with the control group. Furthermore, the levels of MDA, 8-hydroxy-2′-deoxyguanosine and the inflammatory factors IL-6 and monocyte chemoattractant protein-1 were also significantly increased. It was demonstrated that treatment with Dex reverted or attenuated these changes (CLP + Dex vs. CLP; P<0.05), but these protective effects of Dex were reversed by YOH. Moreover, CLP significantly decreased the protein expression levels of glutathione peroxidase 4 (GPX4), SOD and GSH. However, CLP increased expression levels of heme oxygenase-1 (HO-1), transferrin receptor, cleaved caspase 3, inducible nitric oxide synthase and gasdermin D, and iron concentrations. It was found that Dex reversed these changes, but YOH abrogated the protective effects of Dex (CLP + Dex + YOH vs. CLP + Dex; P<0.05). Therefore, the present results suggested that the attenuation of sepsis-induced HO-1 overexpression and iron concentration, and the reduction of ferroptosis via enhancing GPX4, may be the major mechanisms via which Dex alleviates sepsis-induced myocardial cellular injury.

[1]  F. Rossi,et al.  Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in zucker diabetic fatty rats with metabolic syndrome , 2012, Diabetes, obesity & metabolism.

[2]  R. Kaufman,et al.  ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart , 2017, Circulation research.

[3]  R. Ran,et al.  HO-1/EBP interaction alleviates cholesterol-induced hypoxia through the activation of the AKT and Nrf2/mTOR pathways and inhibition of carbohydrate metabolism in cardiomyocytes , 2017, International journal of molecular medicine.

[4]  Minghui Gao,et al.  Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.

[5]  J. Nunn,et al.  Molecular structure of free radicals and their importance in biological reactions. , 1988, British journal of anaesthesia.

[6]  B. Stockwell,et al.  The role of iron and reactive oxygen species in cell death. , 2014, Nature Chemical Biology.

[7]  T. Sharp,et al.  Correlation of Plasma Adrenomedullin to Myocardial Preservation During Open-Heart Surgery , 2000, Pediatric Cardiology.

[8]  S. Cai,et al.  Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats , 2016, Molecular medicine reports.

[9]  L. Kirshenbaum,et al.  Striking a Balance: Autophagy, Apoptosis, and Necrosis in a Normal and Failing Heart , 2012, Current Hypertension Reports.

[10]  M. Irwin,et al.  N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α/HO-1 Signaling in Diabetic Rats , 2013, PloS one.

[11]  D. Klionsky,et al.  Ferroptosis is a type of autophagy-dependent cell death. , 2020, Seminars in cancer biology.

[12]  A. Er,et al.  Effects of drugs used in endotoxic shock on oxidative stress and organ damage markers , 2010, Free radical research.

[13]  Hong Zhu,et al.  GPx4 in Bacterial Infection and Polymicrobial Sepsis: Involvement of Ferroptosis and Pyroptosis. , 2019, Reactive oxygen species.

[14]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[15]  Lorenzo Galluzzi,et al.  Molecular mechanisms of regulated necrosis. , 2014, Seminars in cell & developmental biology.

[16]  D. Reis,et al.  Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. , 1990, The Journal of pharmacology and experimental therapeutics.

[17]  Klitos Konstantinidis,et al.  Mechanisms of cell death in heart disease. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Bornstein,et al.  Regulated Cell Death Seen through the Lens of Islet Transplantation , 2018, Cell transplantation.

[19]  W. Yao,et al.  Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model , 2018, Life sciences.

[20]  Zhongmin Li,et al.  Perioperative Dexmedetomidine Improves Outcomes of Cardiac Surgery , 2013 .

[21]  Lina Yu,et al.  Dexmedetomidine protects against oxygen–glucose deprivation‐induced injury through the I2 imidazoline receptor‐PI3K/AKT pathway in rat C6 glioma cells , 2012, The Journal of pharmacy and pharmacology.

[22]  O. Ighodaro.  Molecular pathways associated with oxidative stress in diabetes mellitus. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  A. Sun,et al.  Programmed necrosis in heart disease: Molecular mechanisms and clinical implications. , 2018, Journal of molecular and cellular cardiology.

[24]  Mingyi Zhao,et al.  NLRP3: A Novel Mediator in Cardiovascular Disease , 2018, Journal of immunology research.

[25]  William C Hahn,et al.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. , 2003, Cancer cell.

[26]  Mingyan Zhao,et al.  Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. , 2017, American journal of translational research.

[27]  Y. Chu,et al.  Comparison of glutathione peroxidase-3 protein expression and enzyme bioactivity in normal subjects and patients with sepsis. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[28]  R. Jaeschke,et al.  Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit , 2013, Critical care medicine.

[29]  H. Bao,et al.  Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice , 2013, Inflammation Research.

[30]  T. Matsui,et al.  Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. , 2018, American journal of physiology. Heart and circulatory physiology.

[31]  F. Gao,et al.  Ferroptosis as a target for protection against cardiomyopathy , 2019, Proceedings of the National Academy of Sciences.

[32]  A. O. Souza,et al.  Brain Oxidative Stress During Experimental Sepsis Is Attenuated by Simvastatin Administration , 2017, Molecular Neurobiology.

[33]  Min‐Young Kwon,et al.  Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death , 2015, Oncotarget.

[34]  Seema Patel.  Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Y. Takemoto,et al.  Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats , 2004, Critical care medicine.

[36]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[37]  Wei Zhao,et al.  Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[39]  Jing Wu,et al.  NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy , 2018, Inflammation.

[40]  K. Girish,et al.  Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[41]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[42]  E. Zakynthinos,et al.  Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies , 2017, Oxidative medicine and cellular longevity.

[43]  M. Wolzt,et al.  Intravenous Heme Arginate Induces HO-1 (Heme Oxygenase-1) in the Human Heart: Randomized, Placebo-Controlled, Safety, and Feasibility Pharmacokinetic Study—Brief Report , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[44]  Jingyao Zhang,et al.  Methane alleviates sepsis-induced injury by inhibiting pyroptosis and apoptosis: in vivo and in vitro experiments , 2019, Aging.

[45]  J E Parrillo,et al.  The cardiovascular pathophysiology of sepsis. , 1989, Annual review of medicine.

[46]  Xing-rong Song,et al.  Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury. , 2015, International journal of clinical and experimental pathology.

[47]  Xiujing Feng,et al.  Dexmedetomidine attenuates lipopolysaccharide‐induced liver oxidative stress and cell apoptosis in rats by increasing GSK‐3&bgr;/MKP‐1/Nrf2 pathway activity via the &agr;2 adrenergic receptor , 2019, Toxicology and applied pharmacology.

[48]  T. Vanden Berghe,et al.  How do we fit ferroptosis in the family of regulated cell death? , 2017, Cell Death and Differentiation.

[49]  M. Singer,et al.  Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit , 1999, Anaesthesia.

[50]  N. Kaludercic,et al.  Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy , 2020, Frontiers in Cardiovascular Medicine.

[51]  Hongguang Chen,et al.  Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy. , 2019, International immunopharmacology.

[52]  R. Gaspari,et al.  Dexmedetomidine use in general anaesthesia. , 2009, Current drug targets.

[53]  Lu Cao,et al.  Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways , 2018, Molecular medicine reports.

[54]  D. Richardson,et al.  Sustained expression of heme oxygenase-1 alters iron homeostasis in nonerythroid cells. , 2012, Free radical biology & medicine.

[55]  Jiahuai Han,et al.  Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis , 2018, Cell Research.